Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AKR1B1 inhibitors(Aldose reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Complications | Preclinical | US | - | |
Diabetes Complications | Preclinical | FR | - |